Pharma Stability: Insights, Guidelines, and Expertise
SOP for Implementing Stability Studies for Oncology Drugs under US FDA and EMA Guidelines Procedure for Stability Testing of Oncology Drugs as per US FDA and EMA Guidelines 1) Purpose The purpose of this SOP is to establish a standardized procedure for conducting stability studies for oncology drugs in compliance with the regulatory guidelines of…
Understanding the Tip: Why visual inspection is critical in container-closure systems: Visual assessment of packaging components is often the first indicator of underlying chemical instability or material interaction. Discoloration of caps, seals, stoppers, or vial interiors may signal oxidation, leachables migration, UV damage, or reactions between the product and packaging. Regular inspection of container-closure systems…
Read More “Always Check for Container-Closure Discoloration During Stability” »
In the pharmaceutical industry, the reliability of stability testing data plays a pivotal role in product quality, regulatory approval, and patient safety. To maintain these standards, it’s essential that all team members involved in stability testing are trained in data integrity principles. This article provides a comprehensive structure for a training module aimed at increasing…
Read More “Training Module: Data Integrity Awareness for Stability Team” »
SOP for Addressing Stability Testing for Drugs in Special Populations as per Regulatory Guidelines Procedure for Stability Testing of Drugs for Special Populations 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing of drugs intended for special populations (e.g., pediatric, geriatric, pregnant women) in compliance with relevant regulatory…
SOP for Conducting Stability Testing for Temperature-Sensitive Biologics in Compliance with Regulatory Guidelines Procedure for Stability Testing of Temperature-Sensitive Biologics 1) Purpose The purpose of this SOP is to provide a structured approach for conducting stability testing of temperature-sensitive biologics in compliance with global regulatory guidelines. This ensures that biologics remain stable and effective under…
Understanding the Tip: Why packaging clarity matters in stability studies: During development, it’s common to initiate stability studies using interim packaging while final commercial packaging is still under design, validation, or procurement. However, the barrier properties, closure integrity, material interaction, and container size can differ significantly. Without clearly documenting the distinction, stability data may be…
Read More “Track Interim vs. Final Packaging Differences in Stability Studies” »
SOP for Implementing Stability Testing for Large Molecule Drugs under FDA Guidelines Procedure for Stability Testing of Large Molecule Drugs According to FDA Guidelines 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing on large molecule drugs (biologics) in accordance with US FDA guidelines. This ensures that such…
Read More “SOP for Implementing Stability Testing for Large Molecule Drugs under FDA Guidelines” »
Understanding the Tip: Why product-specific limits matter for temperature excursions: Temperature excursions—temporary deviations from labeled storage conditions—can occur during manufacturing, transport, or storage. The impact of these deviations varies widely depending on the product’s formulation, sensitivity, packaging, and degradation pathway. A one-size-fits-all limit is inappropriate and risky. Tailoring excursion thresholds based on each product’s risk…
Read More “Set Temperature Excursion Limits Based on Product-Specific Risk Profiles” »
SOP for Conducting Stability Studies in Compliance with Brazilian Health Regulatory Agency (ANVISA) Guidelines Procedure for Stability Testing According to ANVISA Guidelines 1) Purpose The purpose of this SOP is to establish the procedure for conducting stability studies in compliance with the guidelines of the Brazilian Health Regulatory Agency (ANVISA). This ensures that drug products…
Understanding the Tip: Why temperature excursion control is essential: Temperature excursions—temporary deviations from defined storage conditions—can affect a drug product’s stability and efficacy. Not all products respond the same way to temperature stress, so applying generic limits is scientifically unsound and regulatory risky. Instead, limits should be based on the product’s physicochemical properties, degradation profile,…
Read More “Set Temperature Excursion Limits Based on Product-Specific Risk Profiles” »